NCT07781683Not yet recruiting
Clinical Evaluation of Salivary 1,5-Anhydroglucitol in Diabetes
Development and Application of a Novel Noninvasive Salivary 1,5-Anhydroglucitol Detection Technology in Diabetes Management
Source: ClinicalTrials.gov · Last updated 25 Aug 2026
Brief summary (registry, in English)
The goal of this observational study is to evaluate the clinical value of salivary 1,5-anhydroglucitol (1,5-AG) and assess a novel noninvasive detection approach in individuals with and without type 2 diabetes. Additionally, the study will examine the relationships of salivary 1,5-AG with serum 1,5-AG and continuous glucose monitoring (CGM) measures of short-term glycemic control and fluctuations.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 180 (estimated)
- First submitted
- 20 Aug 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 30 Jun 2028
- Lead sponsor
- Shanghai 6th People's Hospital
- Diseases
- Type 2 diabetes
- NCT number
- NCT07781683
What you commit to
- Study type: Observational
- Planned participants: 180
- From 1 Sept 2026 to the primary completion date, 30 Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of systemic glucocorticoid treatment within the previous 6 weeks.
Other illness
- Presence of acute infection.
- Presence of severe oral conditions that may affect saliva collection or measurement.
- History of alcohol abuse or psychiatric disorders, including depression.
Lab values
- Current treatment with sodium-glucose cotransporter 2 (SGLT2) inhibitors.
Other
- Presence of severe hepatic or renal dysfunction.
Who the study is looking for
- Aged between 18 and 80 years.
- Individuals without a history of diabetes, or patients with type 2 diabetes mellitus.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanghai Sixth People's Hospital Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.